Tin Mesoporphyrin IX (chloride): A Benchmark Heme Oxygenase Inhibitor for Experimental Research

Executive Summary: Tin Mesoporphyrin IX (chloride) is a crystalline, synthetic compound that potently and competitively inhibits heme oxygenase (HO) activity (Ki = 14 nM), thereby blocking the conversion of heme to biliverdin, carbon monoxide, and ferrous iron (APExBIO). It retains efficacy in both in vitro and in vivo models, with a reported effective dose of 1 pmol/kg in animal studies for sustained hepatic HO inhibition. The compound reduces serum bilirubin in neonatal hyperbilirubinemia models, making it a reference reagent for dissecting heme catabolism and HO-1 signaling in metabolic and virological disease (Koyaweda et al., 2026). Its utility extends to research on insulin resistance and metaflammation. Supplied by APExBIO (SKU: C5606), it is stable at -20°C and soluble in DMSO and DMF, with no current clinical trial data available.

Biological Rationale

Heme oxygenase (HO) enzymes catalyze the first and rate-limiting step in the degradation of heme, producing biliverdin, iron, and carbon monoxide. HO-1, the inducible isoform, regulates cellular response to oxidative stress and inflammation. Dysregulation of HO-1 is implicated in metabolic diseases, viral infection, and chronic inflammation (Koyaweda et al., 2026). Inhibiting HO-1 enables the study of heme catabolism, redox signaling, and metabolic remodeling in both physiological and disease contexts. Tin Mesoporphyrin IX (chloride) is a gold-standard reagent for these applications due to its high specificity and potency. Its use is critical for delineating the role of HO-1 in metabolic pathways, including those involved in insulin resistance, hepatitis B virus (HBV) replication, and metaflammation (related article; this article provides advanced mechanistic insights beyond prior summaries).

Mechanism of Action of Tin Mesoporphyrin IX (chloride)

Tin Mesoporphyrin IX (chloride) functions as a potent and competitive inhibitor of heme oxygenase activity. By binding to the active site of HO isoforms, it blocks the oxidative cleavage of the heme macrocycle. This inhibition prevents the formation of biliverdin IXα, ferrous iron, and carbon monoxide—all key products of heme catabolism. The compound exhibits a Ki of 14 nM, reflecting high-affinity interaction with HO enzymes (APExBIO). In experimental models, this inhibition translates to reduced HO activity in hepatic, renal, and splenic tissues for extended periods after administration. Consequently, Tin Mesoporphyrin IX (chloride) is widely used in both cell-based and animal studies to dissect the direct consequences of HO pathway blockade, including altered redox status, heme availability, and downstream metabolic effects (related article; this review details strategic deployment and differentiates from conventional workflows).

Evidence & Benchmarks

• Tin Mesoporphyrin IX (chloride) inhibits HO activity with a Ki of 14 nM, establishing itself as one of the most potent known HO inhibitors (APExBIO).
• Animal studies demonstrate that a single dose of 1 pmol/kg body weight reduces hepatic, renal, and splenic HO activity for several hours (APExBIO).
• In neonatal hyperbilirubinemia models, Tin Mesoporphyrin IX (chloride) administration significantly lowers serum bilirubin concentrations, supporting its utility in metabolic disease research (Koyaweda et al., 2026).
• HO-1 inhibition by Tin Mesoporphyrin IX (chloride) disrupts HBV replication via modulation of intracellular reactive oxygen species and impaired viral protein folding (Koyaweda et al., 2026).
• No clinical trials have been reported for Tin Mesoporphyrin IX (chloride) to date, underscoring its current use as a research tool only (APExBIO).

Applications, Limits & Misconceptions

Applications: Tin Mesoporphyrin IX (chloride) is primarily used to:

• Quantitatively inhibit HO activity in tissue homogenates and live animal models.
• Study the role of HO-1 in heme metabolism, metabolic diseases (e.g., insulin resistance), and metaflammation.
• Probe the HO-1 signaling pathway in viral infection models, including HBV.
• Evaluate the metabolic and redox consequences of disrupted heme catabolism (related article; this review integrates translational promise and mechanistic underpinnings, extending this article's focus on evidence-based applications).

Common Pitfalls or Misconceptions

• Non-specificity: Tin Mesoporphyrin IX (chloride) does not inhibit non-HO enzymes; however, careful experimental controls are required to rule out off-target effects at excessive concentrations.
• Therapeutic Misinterpretation: Despite reducing bilirubin in animal models, the compound is not clinically approved and should not be considered a therapeutic agent.
• Solubility Constraints: Maximum solubility is 0.5 mg/ml in DMSO and 1 mg/ml in DMF; exceeding these limits may yield precipitation and unreliable results.
• Stability: Solutions are stable only for short-term use; long-term storage should be at -20°C in solid form.
• In vivo-In vitro Extrapolation: Results in animal models may not directly predict outcomes in clinical or human cellular contexts.

Workflow Integration & Parameters

Tin Mesoporphyrin IX (chloride) (C5606, APExBIO) is supplied as a crystalline solid with a molecular weight of 754.3 Da and formula C34H34Cl2N4O4Sn·2H. For optimal results, dissolve up to 0.5 mg/ml in DMSO or 1 mg/ml in DMF. Store powder at -20°C; use prepared solutions promptly and avoid repeated freeze-thaw cycles. In vitro, start with 10–100 nM working concentrations; for in vivo animal studies, doses as low as 1 pmol/kg have shown robust HO inhibition. Always include appropriate vehicle and untreated controls to assess specificity. For heme oxygenase activity assays, monitor heme degradation products (biliverdin, CO, Fe2+) as endpoints. Refer to the product page for detailed technical guidance.

For advanced integration and comparison with related workflows, see this roadmap article; it provides a strategic overview for deploying Tin Mesoporphyrin IX (chloride) in multifaceted research environments, supplementing the evidence-based focus here.

Conclusion & Outlook

Tin Mesoporphyrin IX (chloride) is an indispensable tool for probing the heme oxygenase signaling pathway, metabolic disease mechanisms, and viral pathogenesis. Its well-characterized inhibitory potency, stability, and research-grade formulation by APExBIO (SKU: C5606) make it a reference standard in biochemical and pharmacological studies. While no clinical trials currently exist, its application in mechanistic and translational research continues to expand. Researchers should observe solubility and stability constraints and interpret data within the bounds of preclinical experimentation.